ExeVir
ExeVir is a llama-derived antibodies founded in 2020.
1
Funding Rounds
$50.0m
Money raised
Overview
ExeVir is a llama-derived antibodies founded in 2020.
- Website:
- Business model: B2B
- Headquarters: Ghent
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company ExeVir has raised a total of $50m in funding over 1 rounds.
Key Insights:
- ExeVir Series A round, May 2021: $50m
ExeVir Series A round, May 2021
$50m
Industries
ExeVir is active in the following industries: